Iterum Therapeutics plc (ITRMF) Interest & Investment Income (2024 - 2025)
Iterum Therapeutics (ITRMF) posted quarterly Interest & Investment Income of $121000.0 for Q3 2025, down 27.11% year-over-year from $166000.0 in Q3 2024, and down 9.02% quarter-over-quarter from $133000.0 in Q2 2025.
Iterum Therapeutics plc (ITRMF) Interest & Investment Income (2024 - 2025) Analysis & Trends
Iterum Therapeutics' Interest & Investment Income history runs 2 years deep, the most recent figure standing at $121000.0 for Q3 2025.
- In Q3 2025, Interest & Investment Income fell 27.11% year-over-year to $121000.0; the TTM figure through Sep 2025 stood at $588000.0 (changed N/A YoY), while the FY2024 annual figure was $789000.0, down 54.18% from the prior year.
- Interest & Investment Income for Q3 2025 stood at $121000.0, down from $133000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $262000.0 in Q1 2024, with the low at $121000.0 in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 121,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Mar 31, 2025 | 152,000.00 |
| Dec 31, 2024 | 182,000.00 |
| Sep 30, 2024 | 166,000.00 |
| Jun 30, 2024 | 179,000.00 |
| Mar 31, 2024 | 262,000.00 |